X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
- chromosome 13 -
| Symbol | GoldenPath (Mb) | Location | Description |
|---|---|---|---|
| ZMYM2 | 19430.810 | 13q11-q12 | zinc finger, MYM-type 2 |
| GJB2 | 19659.606 | 13q11-q12 | gap junction protein, beta 2, 26kDa |
| GJB6 | 19694.101 | 13q11-q12.1|13q12 | gap junction protein, beta 6, 30kDa |
| IFT88 | 20039.208 | 13q12.1 | intraflagellar transport 88 homolog (Chlamydomonas) |
| BRCD1 | 20039.208 | - | Breast cancer, ductal, suppressor-1 |
| XRS | 20039.208 | 13q14 | X-ray sensitivity |
| LATS2 | 20445.176 | 13q11-q12 | LATS, large tumor suppressor, homolog 2 (Drosophila) |
| SAP18 | 20612.685 | 13q12.11 | Sin3A-associated protein, 18kDa |
| FGF9 | 21143.875 | 13q11-q12 | fibroblast growth factor 9 (glia-activating factor) |
| SACS | 22800.967 | 13q12 | spastic ataxia of Charlevoix-Saguenay (sacsin) |
| TNFRSF19 | 23042.723 | 13q12.11-q12.3 | tumor necrosis factor receptor superfamily, member 19 |
| MIPEP | 23202.328 | 13q12 | mitochondrial intermediate peptidase |
| PCOTH | 23361.028 | 13q12 | prostate collagen triple helix |
| SPATA13 | 23632.887 | 13q12.12 | spermatogenesis associated 13 |
| C1QTNF9 | 23781.716 | 13q12.12 | C1q and tumor necrosis factor related protein 9 |
| PARP4 | 23893.075 | 13q11 | poly (ADP-ribose) polymerase family, member 4 |
| ATP12A | 24152.695 | 13q12.12|13q12.1-q12.3 | ATPase, H+/K+ transporting, nongastric, alpha polypeptide |
| RNF17 | 24236.301 | 13q12.12 | ring finger protein 17 |
| CENPJ | 24354.412 | 13q12.12 | centromere protein J |
| ATP8A2 | 24844.209 | 13q12 | ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
| RNF6 | 25684.906 | 13q12.2 | ring finger protein (C3H2C3 type) 6 |
| CDK8 | 25726.756 | 13q12 | cyclin-dependent kinase 8 |
| WASF3 | 26029.840 | 13q12 | WAS protein family, member 3 |
| RASL11A | 26742.464 | - | RAS-like, family 11, member A |
| GTF3A | 26897.547 | 13q12.3-q13.1 | general transcription factor IIIA |
| LNX2 | 27018.050 | 13q12.2 | ligand of numb-protein X 2 |
| PDX1 | 27392.157 | 13q12.1 | pancreatic and duodenal homeobox 1 |
| CDX2 | 27434.279 | 13q12.3 | caudal type homeobox 2 |
| FLT3 | 27475.411 | 13q12 | fms-related tyrosine kinase 3 |
| FLT1 | 27774.389 | 13q12 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
| HMGB1 | 29930.881 | 13q12 | high-mobility group box 1 |
| ALOX5AP | 30207.669 | 13q12 | arachidonate 5-lipoxygenase-activating protein |
| HSPH1 | 30608.765 | 13q12.3 | heat shock 105kDa/110kDa protein 1 |
| BRCA2 | 31787.617 | 13q12.3 | breast cancer 2, early onset |
| PDS5B | 32058.624 | 13q12.3 | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
| STARD13 | 32575.307 | 13q12-q13 | StAR-related lipid transfer (START) domain containing 13 |
| RFC3 | 33290.206 | 13q12.3-q13 | replication factor C (activator 1) 3, 38kDa |
| NBEA | 34414.456 | 13q13 | neurobeachin |
| DCLK1 | 35243.478 | 13q13 | doublecortin-like kinase 1 |
| SPG20 | 35773.777 | 13q13.3 | spastic paraplegia 20 (Troyer syndrome) |
| CCNA1 | 35904.495 | 13q12.3-q13 | cyclin A1 |
| FAM48A | 36481.453 | 13q13.3 | family with sequence similarity 48, member A |
| POSTN | 37034.780 | 13q13.3 | periostin, osteoblast specific factor |
| TRPC4 | 37108.795 | 13q13.1-q13.2 | transient receptor potential cation channel, subfamily C, member 4 |
| LHFP | 38815.030 | 13q12 | lipoma HMGIC fusion partner |
| TNAP | 38913.303 | - | TRAFs and NIK-associated protein |
| FOXO1 | 40027.801 | 13q14.1 | forkhead box O1 |
| ELF1 | 40404.165 | 13q13 | E74-like factor 1 (ets domain transcription factor) |
| C13orf15 | 40929.542 | 13q14.11 | chromosome 13 open reading frame 15 |
| AKAP11 | 41744.289 | 13q14.11 | A kinase (PRKA) anchor protein 11 |
| TNFSF11 | 42043.795 | 13q14 | tumor necrosis factor (ligand) superfamily, member 11 |
| EPSTI1 | 42360.122 | 13q13.3 | epithelial stromal interaction 1 (breast) |
| DNAJC15 | 42495.362 | 13q14.1 | DnaJ (Hsp40) homolog, subfamily C, member 15 |
| TSC22D1 | 43905.661 | 13q14 | TSC22 domain family, member 1 |
| TPT1 | 44809.304 | 13q12-q14 | tumor protein, translationally-controlled 1 |
| CPB2 | 45525.323 | 13q14.11 | carboxypeptidase B2 (plasma) |
| LCP1 | 45598.060 | 13q14.3 | lymphocyte cytosolic protein 1 (L-plastin) |
| HTR2A | 46305.514 | 13q14-q21 | 5-hydroxytryptamine (serotonin) receptor 2A |
| ITM2B | 47705.309 | 13q14.3 | integral membrane protein 2B |
| RB1 | 47775.884 | 13q14.2 | retinoblastoma 1 (including osteosarcoma) |
| P2RY5 | 47883.185 | 13q14 | purinergic receptor P2Y, G-protein coupled, 5 |
| RCBTB2 | 47961.102 | 13q14.3 | regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
| PHF11 | 48968.529 | 13q14.3 | PHD finger protein 11 |
| RCBTB1 | 49004.083 | 13q14 | regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 |
| ARL11 | 49100.625 | 13q14.3 | ADP-ribosylation factor-like 11 |
| KPNA3 | 49171.463 | 13q14.3 | karyopherin alpha 3 (importin alpha 4) |
| TRIM13 | 49469.144 | 13q14 | tripartite motif-containing 13 |
| KCNRG | 49487.391 | 13q14.3 | potassium channel regulator |
| DLEU2 | 49511.144 | 13q14.3 | deleted in lymphocytic leukemia, 2 |
| DLEU1 | 49554.573 | 13q14.3 | deleted in lymphocytic leukemia, 1 |
| FAM10A4 | 49644.154 | 13q14.3 | family with sequence similarity 10, member A4 |
| DLEU7 | 50184.760 | 13q14.3 | deleted in lymphocytic leukemia, 7 |
| RNASEH2B | 50381.928 | 13q14.3 | ribonuclease H2, subunit B |
| INTS6 | 50921.624 | 13q14.12-q14.2 | integrator complex subunit 6 |
| ATP7B | 51404.806 | 13q14.3 | ATPase, Cu++ transporting, beta polypeptide |
| NEK5 | 51536.903 | 13q14.3 | NIMA (never in mitosis gene a)-related kinase 5 |
| NEK3 | 51604.781 | 13q14.13 | NIMA (never in mitosis gene a)-related kinase 3 |
| OLFM4 | 52500.973 | 13q21.1 | olfactomedin 4 |
| PIBF1 | 72254.231 | 13q22.1 | progesterone immunomodulatory binding factor 1 |
| KLF5 | 72531.143 | 13q22.1 | Kruppel-like factor 5 (intestinal) |
| KLF12 | 73158.151 | 13q22 | Kruppel-like factor 12 |
| TBC1D4 | 74756.810 | 13q22.2 | TBC1 domain family, member 4 |
| UCHL3 | 75021.928 | 13q22.2 | ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
| SCEL | 77007.860 | 13q22 | sciellin |
| EDNRB | 77368.544 | 13q22 | endothelin receptor type B |
| POU4F1 | 78071.233 | 13q31.1 | POU class 4 homeobox 1 |
| RBM26 | 78792.100 | 13q31.1 | RNA binding motif protein 26 |
| SPRY2 | 79808.115 | 13q31.1 | sprouty homolog 2 (Drosophila) |
| GPC5 | 90848.888 | 13q32 | glypican 5 |
| DCT | 93889.842 | 13q32 | dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) |
| ABCC4 | 94470.084 | 13q32 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
| CLDN10 | 94883.859 | 13q31-q34 | claudin 10 |
| DNAJC3 | 95127.484 | 13q32 | DnaJ (Hsp40) homolog, subfamily C, member 3 |
| PSMC6P1 | 95541.094 | 8q12.1 | proteasome (prosome, macropain) 26S subunit, ATPase, 6 pseudogene |
| RAP2A | 96884.477 | 13q34 | RAP2A, member of RAS oncogene family |
| RANBP5 | 97403.930 | 13q32.2 | RAN binding protein 5 |
| KRAS1P | 97403.930 | 6p12-p11 | v-Ki-ras1 Kirsten rat sarcoma 1 viral oncogene homolog, processed pseudogene |
| FARP1 | 97593.435 | 13q32.2 | FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
| STK24 | 97900.456 | 13q31.2-q32.3 | serine/threonine kinase 24 (STE20 homolog, yeast) |
| SLC15A1 | 98134.057 | 13q33-q34 | solute carrier family 15 (oligopeptide transporter), member 1 |
| EBVS1 | 98744.791 | 1p35 | Epstein Barr virus insertion site 1 |
| PCCA | 99539.338 | 13q32 | propionyl Coenzyme A carboxylase, alpha polypeptide |
| FGF14 | 101173.038 | 13q34 | fibroblast growth factor 14 |
| ERCC5 | 102296.175 | 13q22|13q33 | excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) |
| SLC10A2 | 102494.351 | 13q33 | solute carrier family 10 (sodium/bile acid cotransporter family), member 2 |
| EFNB2 | 105940.099 | 13q33 | ephrin-B2 |
| LIG4 | 107657.794 | 13q33-q34 | ligase IV, DNA, ATP-dependent |
| TNFSF13B | 107719.978 | 13q32-q34 | tumor necrosis factor (ligand) superfamily, member 13b |
| IRS2 | 109204.185 | 13q34 | insulin receptor substrate 2 |
| COL4A1 | 109599.311 | 13q34 | collagen, type IV, alpha 1 |
| COL4A2 | 109757.632 | 13q34 | collagen, type IV, alpha 2 |
| RAB20 | 109973.415 | 13q34 | RAB20, member RAS oncogene family |
| ING1 | 110163.084 | 13q34 | inhibitor of growth family, member 1 |
| ANKRD10 | 110328.889 | 13q34 | ankyrin repeat domain 10 |
| ARHGEF7 | 110565.783 | 13q34 | Rho guanine nucleotide exchange factor (GEF) 7 |
| SOX1 | 111769.914 | 13q34 | SRY (sex determining region Y)-box 1 |
| MCF2L | 112704.069 | 13q34 | MCF.2 cell line derived transforming sequence-like |
| F7 | 112808.106 | 13q34 | coagulation factor VII (serum prothrombin conversion accelerator) |
| F10 | 112825.114 | 13q34 | coagulation factor X |
| CUL4A | 112911.087 | 13q34 | cullin 4A |
| LAMP1 | 112999.470 | 13q34 | lysosomal-associated membrane protein 1 |
| TFDP1 | 113287.057 | 13q34 | transcription factor Dp-1 |
| GRK1 | 113369.598 | 13q34 | G protein-coupled receptor kinase 1 |
| GAS6 | 113546.913 | 13q34 | growth arrest-specific 6 |
| RASA3 | 113765.297 | 13q34 | RAS p21 protein activator 3 |
| CDC16 | 114018.464 | 13q34 | cell division cycle 16 homolog (S. cerevisiae) |